Regulus Therapeutics Inc. (RGLS)
NASDAQ: RGLS · Real-Time Price · USD
1.685
-0.115 (-6.39%)
At close: Apr 4, 2025, 4:00 PM
1.701
+0.015 (0.92%)
After-hours: Apr 4, 2025, 7:50 PM EDT

Regulus Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-46.36-30.04-28.32-27.81-15.73
Upgrade
Depreciation & Amortization
0.350.230.120.460.47
Upgrade
Loss (Gain) From Sale of Investments
-1.56-0.16-0.19--
Upgrade
Stock-Based Compensation
7.742.82.182.922.61
Upgrade
Other Operating Activities
0.040.140.13-0.620.15
Upgrade
Change in Accounts Receivable
---0.50.64
Upgrade
Change in Inventory
-0.48--0.30.61
Upgrade
Change in Accounts Payable
0.740.03-0.11-0.25-0.79
Upgrade
Change in Unearned Revenue
-----0.01
Upgrade
Change in Other Net Operating Assets
-2.140.230.660.36-0.5
Upgrade
Operating Cash Flow
-41.67-26.77-25.53-24.13-12.54
Upgrade
Capital Expenditures
-0.34-0.61-0.36-0.25-
Upgrade
Sale of Property, Plant & Equipment
-0---
Upgrade
Sale (Purchase) of Intangibles
-----0.01
Upgrade
Investment in Securities
-35.6415.1-14.76--
Upgrade
Investing Cash Flow
-35.9814.49-15.12-0.25-0.01
Upgrade
Long-Term Debt Issued
----0.66
Upgrade
Long-Term Debt Repaid
-1.38-3.3--0.08-10.28
Upgrade
Net Debt Issued (Repaid)
-1.38-3.3--0.08-9.62
Upgrade
Issuance of Common Stock
93.9315.124.4953.8219.13
Upgrade
Other Financing Activities
-0.13----
Upgrade
Financing Cash Flow
92.4211.824.4953.749.51
Upgrade
Net Cash Flow
14.76-0.46-36.1629.36-3.03
Upgrade
Free Cash Flow
-42.01-27.38-25.89-24.38-12.54
Upgrade
Free Cash Flow Margin
-----125.28%
Upgrade
Free Cash Flow Per Share
-0.75-1.44-1.70-2.85-3.58
Upgrade
Cash Interest Paid
0.070.450.490.731.36
Upgrade
Cash Income Tax Paid
00000
Upgrade
Levered Free Cash Flow
-25.53-16.93-14.35-15.81-6.13
Upgrade
Unlevered Free Cash Flow
-25.43-16.56-13.92-15.28-5
Upgrade
Change in Net Working Capital
1.9-0.47-1.791.02-0.77
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q